Multiple scientific fields pertaining to inflammation, including the fields of cardiovascular, infection and cancer research, are increasingly contributing to our understanding of rheumatoid arthritis (RA). In 2017, such research has helped develop our understanding of RA comorbidity, the link between RA pathogenesis and infection, and the effects of new therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).
Dutzan, N. et al. On-going mechanical damage from mastication drives homeostatic Th17 cell responses at the oral barrier. Immunity 46, 133–147 (2017).
Belkhir, R. et al. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Ann. Rheum. Dis. 76, 1747–1750 (2017).
Hong, S. S. et al. PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints. Nat. Commun. 8, 146 (2017).
Robertson, J. et al. Interleukin-6 blockade raises LDL via reduced catabolism rather than via increased synthesis: a cytokine-specific mechanism for cholesterol changes in rheumatoid arthritis. Ann. Rheum. Dis. 76, 1949–1952 (2017).
Hot, A., Lavocat, F., Lenief, V. & Miossec, P. Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells. Ann. Rheum. Dis. 72, 754–760 (2013).
Miossec, P., Cavender, D. & Ziff, M. Production of interleukin 1 by human endothelial cells. J. Immunol. 136, 2486–2491 (1986).
Ridker, P. M. et al. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833–1842 (2017).
Pfeifle, R. et al. Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease. Nat. Immunol. 18, 104–113 (2017).
Yamanishi, Y. et al. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc. Natl Acad. Sci. USA 99, 10025–10030 (2002).
Acknowledgements
The work of the author has been supported by the OpeRa IHU programme and the Institut Universitaire de France. P.M. is a senior member of the Institut Universitaire de France.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Miossec, P. Connectivity to other fields brings new ideas. Nat Rev Rheumatol 14, 65–66 (2018). https://doi.org/10.1038/nrrheum.2017.215
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2017.215